Literature DB >> 15551741

Fluorescence in situ hybridization on formalin-fixed and paraffin-embedded tissue: optimizing the method.

Bodil L Petersen1, Mette C Sørensen, Sanni Pedersen, Marianne Rasmussen.   

Abstract

Fluorescence in situ hybridization (FISH) is widely used to study numerical and structural genetic abnormalities in both metaphase and interphase cells. The technique is based on the hybridization of labeled probes to complementary sequences in the DNA or RNA of the cells. Interphase FISH is most often applied on cytologic material such as hematologic smears or imprints, but the method is also used to study genetic changes in tissue sections when morphology is important or when cytologic material is not available. In cases in which the presence of intact nuclei is of importance, such as quantitation of signals as in triploidy, it is possible to isolate nuclei from paraffin-embedded tissue. However, using formalin-fixed paraffin-embedded tissue, either in thin sections or as isolated nuclei, one encounters a range of technical problems, paralleling those met in immunohistochemistry. Variations in time lapse between removal of tissue and fixation, duration of fixation, enzymatic pretreatment, hybridization conditions, and posthybridization washing conditions are important factors in the hybridization. In this study, we have listed the results of a systematic approach to improve FISH on isolated nuclei and tissue sections from formalin-fixed, paraffin-embedded tissue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15551741     DOI: 10.1097/00129039-200409000-00013

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  7 in total

1.  A new method for real-time evaluation of pepsin digestion of paraffin-embedded tissue sections, prior to fluorescence in situ hybridisation.

Authors:  Xiaojing Teng; Shuhong Zhang; Wei Liu; Kuo Bi; Lei Zhang
Journal:  Virchows Arch       Date:  2017-02-25       Impact factor: 4.064

2.  Standardization and optimization of fluorescence in situ hybridization (FISH) for HER-2 assessment in breast cancer: A single center experience.

Authors:  Magdalena Bogdanovska-Todorovska; Gordana Petrushevska; Vesna Janevska; Liljana Spasevska; Slavica Kostadinova-Kunovska
Journal:  Bosn J Basic Med Sci       Date:  2018-05-20       Impact factor: 3.363

3.  HER2 status determination: analyzing the problems to find the solutions.

Authors:  Irene Terrenato; Ilaria Pennacchia; Simonetta Buglioni; Marcella Mottolese; Vincenzo Arena
Journal:  Medicine (Baltimore)       Date:  2015-04       Impact factor: 1.889

4.  Genetic Heterogeneity of HER2 Amplification and Telomere Shortening in Papillary Thyroid Carcinoma.

Authors:  Paola Caria; Silvia Cantara; Daniela Virginia Frau; Furio Pacini; Roberta Vanni; Tinuccia Dettori
Journal:  Int J Mol Sci       Date:  2016-10-21       Impact factor: 5.923

5.  Fast fluorescence in situ hybridisation for the enhanced detection of MET in non-small cell lung cancer.

Authors:  David Jonathan Duncan; Michel Erminio Vandenberghe; Marietta Louise Juanita Scott; Craig Barker
Journal:  PLoS One       Date:  2019-10-15       Impact factor: 3.240

6.  Distinct microbiome profiles and biofilms in Leishmania donovani-driven cutaneous leishmaniasis wounds.

Authors:  T D Jayasena Kaluarachchi; Paul M Campbell; Rajitha Wickremasinghe; Shalindra Ranasinghe; Renu Wickremasinghe; Surangi Yasawardene; Hiromel De Silva; Chandrani Menike; M C K Jayarathne; Subodha Jayathilake; Ayomi Dilhari; Andrew J McBain; Manjula M Weerasekera
Journal:  Sci Rep       Date:  2021-11-30       Impact factor: 4.379

7.  Diagnosing human cutaneous leishmaniasis using fluorescence in situ hybridization.

Authors:  Thilini Jayasena Kaluarachchi; Rajitha Wickremasinghe; Manjula Weerasekera; Surangi Yasawardene; Andrew J McBain; Bandujith Yapa; Hiromel De Silva; Chandranie Menike; Subodha Jayathilake; Anuradha Munasinghe; Renu Wickremasinghe; Shalindra Ranasinghe
Journal:  Pathog Glob Health       Date:  2021-03-09       Impact factor: 2.894

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.